戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 erican women are at increased risk of having peripartum cardiomyopathy.
2 imilar to those of patients with traditional peripartum cardiomyopathy.
3 entricular function in women presenting with peripartum cardiomyopathy.
4                    Although the frequency of peripartum cardiomyopathy (185 of 100,000 deliveries) at
5 ne hundred women met traditional criteria of peripartum cardiomyopathy; 23 were diagnosed with pregna
6 e: idiopathic cardiomyopathy (616 patients), peripartum cardiomyopathy (51); and cardiomyopathy due t
7 verexpression of Galpha(q) exhibit a lethal, peripartum cardiomyopathy accompanied by apoptosis.
8  have also been linked to conditions such as peripartum cardiomyopathy and chemotherapy-induced cardi
9                     A comparison between the peripartum cardiomyopathy and early pregnancy-associated
10 rdiology, we identified 44 women who had had peripartum cardiomyopathy and had a total of 60 subseque
11 action <45%) is crucial for the diagnosis of peripartum cardiomyopathy and the exclusion of other cau
12                       She was diagnosed with peripartum cardiomyopathy and treatment with digoxin and
13  Primary study end points were preeclampsia, peripartum cardiomyopathy, and heart failure.
14 adjusted OR [aOR], 2.12; 95% CI, 2.07-2.17), peripartum cardiomyopathy (aOR, 4.42; 95% CI, 3.79-5.13)
15 ) 1.37 (95% confidence interval 1.27-1.47)], peripartum cardiomyopathy [aOR 2.10 (1.11-3.99)], and ar
16                                Patients with peripartum cardiomyopathy appear to have a better progno
17  Anthracycline-associated cardiomyopathy and peripartum cardiomyopathy are nonischemic cardiomyopathi
18 ons with RA had higher risk of preeclampsia, peripartum cardiomyopathy, arrhythmias, acute kidney inj
19 gy, clinical presentation, and management of peripartum cardiomyopathy, as well as the current knowle
20 shed from 1966 to July 1999, using the terms peripartum cardiomyopathy, cardiomyopathy, and pregnancy
21 This Seminar summarises current knowledge of peripartum cardiomyopathy genetics, pathophysiology, dia
22 idiopathic cardiomyopathy, the patients with peripartum cardiomyopathy had better survival (adjusted
23                                 For decades, peripartum cardiomyopathy has remained an enigma.
24                                              Peripartum cardiomyopathy has variable disease progressi
25                           Mortality rates in peripartum cardiomyopathy have decreased, and this is mo
26 mation has also indicated that many cases of peripartum cardiomyopathy have genetic underpinnings.
27 sk of complications, including preeclampsia, peripartum cardiomyopathy, heart failure, arrhythmias, A
28 de spectrum of cardiomyopathies that include peripartum cardiomyopathy, hypertrophic cardiomyopathy,
29 Conversely, sNix protected against apoptotic peripartum cardiomyopathy in G(alpha)q-overexpressors.
30 view are to describe the clinical profile of peripartum cardiomyopathy in the United States and to pr
31                                              Peripartum cardiomyopathy is a cardiomyopathy of unknown
32                                              Peripartum cardiomyopathy is a disease with considerable
33                                              Peripartum cardiomyopathy is a form of systolic heart fa
34                                              Peripartum cardiomyopathy is a heart disease of unknown
35                                              Peripartum cardiomyopathy is a potentially life-threaten
36                                              Peripartum cardiomyopathy is a pregnancy-associated myoc
37                                              Peripartum cardiomyopathy is a rare and sometimes fatal
38                                              Peripartum cardiomyopathy is a rare complication of preg
39                                              Peripartum cardiomyopathy is a rare lethal disease about
40 sequent pregnancy in women with a history of peripartum cardiomyopathy is associated with a significa
41 search in the past decade has suggested that peripartum cardiomyopathy is caused by vascular dysfunct
42                                              Peripartum cardiomyopathy is increasingly recognised and
43                                Management of peripartum cardiomyopathy is largely limited to the same
44                                     Although peripartum cardiomyopathy is the most common diagnosis f
45 hy and myocarditis, but its effectiveness in peripartum cardiomyopathy is unknown.
46 cular function and survival in the Galpha(q) peripartum cardiomyopathy model.
47 5), hypertrophic cardiomyopathy (n = 40) and peripartum cardiomyopathy (n = 69) for disease-causing P
48                                              Peripartum cardiomyopathy occurs globally in all ethnic
49            Based on clinical observations of peripartum cardiomyopathy patients and the high rate of
50                                              Peripartum cardiomyopathy patients from the EORP PPCM re
51                                              Peripartum cardiomyopathy patients had a high incidence
52                                              Peripartum cardiomyopathy patients had a mean age of 31+
53                                  For >50% of peripartum cardiomyopathy patients, left ventricular fun
54 this small retrospective study of women with peripartum cardiomyopathy, patients treated with immune
55                                              Peripartum cardiomyopathy (PPCM) and dilated cardiomyopa
56 t ventricular (LV) recovery in patients with peripartum cardiomyopathy (PPCM) and to record rates of
57 c shock (CS) is a recognized complication of peripartum cardiomyopathy (PPCM) associated with poor pr
58                                     The term peripartum cardiomyopathy (PPCM) describes dilated cardi
59                                              Peripartum cardiomyopathy (PPCM) disproportionately affe
60 bsequent pregnancies (SSPs) in patients with peripartum cardiomyopathy (PPCM) have not been analyzed.
61                          The epidemiology of peripartum cardiomyopathy (PPCM) in Europe is poorly und
62         Nigeria has the highest incidence of peripartum cardiomyopathy (PPCM) in the world.
63                                              Peripartum cardiomyopathy (PPCM) is a disease that occur
64                                              Peripartum cardiomyopathy (PPCM) is a life-threatening d
65                                              Peripartum cardiomyopathy (PPCM) is a life-threatening h
66                                              Peripartum cardiomyopathy (PPCM) is a life-threatening p
67                                              Peripartum cardiomyopathy (PPCM) is a potentially fatal
68                                              Peripartum cardiomyopathy (PPCM) is a pregnancy-associat
69                                              Peripartum cardiomyopathy (PPCM) is a rare life-threaten
70                                              Peripartum cardiomyopathy (PPCM) is an idiopathic form o
71                                              Peripartum cardiomyopathy (PPCM) is an often fatal disea
72                                              Peripartum cardiomyopathy (PPCM) is due to dysregulated
73                                              Peripartum cardiomyopathy (PPCM) is the unexplained loss
74  this study was to systematically review the peripartum cardiomyopathy (PPCM) literature and determin
75                                              Peripartum cardiomyopathy (PPCM) remains a major cause o
76                                              Peripartum cardiomyopathy (PPCM) remains a serious threa
77 psia is a risk factor for the development of peripartum cardiomyopathy (PPCM), but it is unknown whet
78          Black women are at greater risk for peripartum cardiomyopathy (PPCM).
79 imbalance during pregnancy may lead to acute peripartum cardiomyopathy (PPCM).
80  or in the postpartum period, manifesting as peripartum cardiomyopathy (PPCM).
81 d disruptions in these processes can lead to peripartum cardiomyopathy (PPCM).
82 left ventricular (LV) recovery in women with peripartum cardiomyopathy (PPCM).
83 describe the characteristics and outcomes of peripartum cardiomyopathy (PPCMP) patients who received
84 r-specific antibodies (n=69, 57%), and prior peripartum cardiomyopathy pretransplant (n=57, 47%).
85                                              Peripartum cardiomyopathy seems to affect women in diffe
86 omen had a 15.7-fold higher relative risk of peripartum cardiomyopathy than non-African Americans (od
87 men have significantly higher odds of having peripartum cardiomyopathy that could not be explained by
88 tutes of Health (NIH) convened a Workshop on Peripartum Cardiomyopathy to foster a systematic review
89 ared the clinical outcomes of six women with peripartum cardiomyopathy treated with intravenous immun
90                             The frequency of peripartum cardiomyopathy varies markedly between Africa
91 U.S. studies confirmed that the frequency of peripartum cardiomyopathy was significantly higher among
92 icity remained a significant risk factor for peripartum cardiomyopathy when other risk factors were c
93       Given the poor prognosis of women with peripartum cardiomyopathy who do not improve, this thera
94 ons of pregnancy, including preeclampsia and peripartum cardiomyopathy, with a focus on pathological
95 thy was a prospective 30-center study of 100 peripartum cardiomyopathy women with LV ejection fractio
96 igeria has the highest reported incidence of peripartum cardiomyopathy worldwide.